Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
Clinical trial NCT00399529 · COMPLETED
Trial details
- NCT number
- NCT00399529
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2010-02-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.